Skip to main content
Topical MEK inhibition as a new modality for inflammatory skin diseases and cancers

Topical MEK inhibition as a new modality for inflammatory skin diseases and cancers

Unmet Need Inflammatory skin conditions affect many people, with a wide range of severities. Common skin disorders, such as psoriasis and atopic dermatitis, affect close to 20% of the population. Skin lesions associated with bone…

Read More

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us